Eunsung Global Corp. is a South Korean manufacturer of medical aesthetic equipment, established in 1995. The company's headquarters are located in Wonju-si, Gangwon-do, Republic of Korea, with an additional office in Seoul. Eunsung Global Corp. is a private company with an estimated annual revenue between $10 million and $50 million and a workforce of 101-500 employees.
Eunsung Global Corp. specializes in manufacturing and providing a range of body and skin care equipment. Their product lines include medical aesthetic systems, body care systems, and facial care systems, featuring technologies such as HIFU (High Intensity Focused Ultrasound), laser, radiofrequency (RF), cryotherapy, and aqua therapy devices. They export their products to over 70 countries and have more than 100 partners worldwide.
Eunsung Global Corp. is primarily an operating company. Their single tracked patent litigation case shows them as a plaintiff in a Patent Trial and Appeal Board (PTAB) proceeding.
In the tracked case, Eunsung Global Corp. v. HydraFacial LLC, Eunsung Global Corp. filed a petition for inter partes review against HydraFacial LLC concerning U.S. Patent No. 11,865,287 B2, which relates to microdermabrasion systems. HydraFacial LLC, a company that designs and sells patented microdermabrasion and hydradermabrasion systems, had previously accused Eunsung Global Corp. of infringing this patent in district court and International Trade Commission (ITC) proceedings. The PTAB denied Eunsung Global Corp.'s petition for inter partes review on April 11, 2025.